Avastin’s new licence ‘more cost-effective’
January 30, 2008Sales and Marketing
Avastin has won a broader European licence for metastatic colorectal cancer, a move manufacturer Roche believes will make it more …
PM Society Awards
January 28, 2008Medical Communications advertising, awards
The Pharmaceutical Marketing Society’s Advertising Awards added their customary sparkle to the grey month of January, and celebrated the best …
‘Alsace Biovalley’ brand launched to promote region’s biotech innovation
January 28, 2008Research and Development Alsace, France, biotech
France has re-branded its leading biotech cluster the ‘Alsace Biovalley’ to help the region compete for investment in Europe and …
Novartis’ European chief says ‘Geotailoring’ will speed decision making and bring it closer to customers
January 28, 2008Sales and Marketing Eric Cornut, Novartis
Q: Europe’s biggest market Germany is preparing for some major reforms at the moment. How is Novartis responding to that …
Jimenez aims for savings and marketing rejuvenation
January 28, 2008Sales and Marketing Jimenez, Jiminez, Novartis
The head of Novartis’ pharmaceutical business Joe Jimenez has set out his plans to make the division more efficient and …
Pfizer sales dip during year of restructuring
January 25, 2008Sales and Marketing generics
Pfizer’s pharmaceutical sales fell slightly last year, hit by patent expiries and difficult market conditions for its leading drug Lipitor. …
Avandia hit by further restrictions
January 25, 2008Sales and Marketing reg, safety
GlaxoSmithKline has strengthened the safety warnings on its diabetes drug Avandia following recommendations from European regulators. The drug was hit …
Avastin launched in UK for kidney cancer
January 25, 2008Sales and Marketing avastin, rcc
Avastin has been launched in the UK as a first-line treatment for renal cell carcinoma (RCC) to be used in …
PR firm Chamberlain opens European office
January 25, 2008Medical Communications PR
American PR firm Chamberlain is to expand into Europe with the opening of new operations in London. Chamberlain Healthcare Public …
Athena picks up account for key Bayer Schering product
January 24, 2008Medical Communications
Bayer Schering Pharma has appointed Athena Medical PR to handle the UK PR campaign for its anti-coagulant Xarelto ahead of …
NICE contributes to government’s anti-obesity vision
January 24, 2008Sales and Marketing hc
The rise of obesity in Britain could be halted if exercise were built into individual daily routines, according to new …
Genmab’s MabThera rival enters phase III
January 24, 2008Sales and Marketing
Genmab and GSK's new biotech drug HuMax has entered phase III trials for use in rheumatoid arthritis, the first of …
Pharmafocus: The NHS in Review
January 24, 20082007, NHS, healthcare, year in review
First, the good news. So easy to overlook when the headlines are filled with tales of threats to close A&E …
Latest news from Datamonitor
January 24, 2008Research and Development
Access licenses MuGard to Rhei Pharmaceuticals Access Pharmaceuticals and Rhei Pharmaceuticals have signed a definitive licensing agreement under which Rhei …
Roche invests in Germany and Swiss biotech sites
January 18, 2008Manufacturing and Production, Research and Development
Swiss pharmaceutical company Roche is to invest $390 million (430 million Swiss francs) in three of its European sites to …
Pharma companies raided over alleged generic blocking
January 18, 2008Sales and Marketing
Pharmaceutical companies across Europe have been raided by EU investigators who suspect illegal moves to block the launch of cheaper …
Pharmafocus: A Year in Review
January 17, 2008Research and Development, Sales and Marketing 2007, biotech, pharma, year in review
A look back at some of the biggest stories to affect the UK pharmaceutical industry in 2007, including a string …
US problems hit Novartis
January 17, 2008Sales and Marketing generics
The entry of three generic competitors and the withdrawal of irritable bowel drug Zelnorm wiped billions off Novartis' revenues in …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
